Expression vectors, transfection systems, and method of use thereof
AssigneeChiron Corporation
InventorsMichael Innis, Elizabeth M. Scott
Life of this patent
Estimating the term…
Abstract
Expression vectors and transfection systems providing high expression of a desired polypeptide are provided. Also provided are methods of using the expression vectors and transfection systems and mammalian cells modified by these compositions and methods.
Claims43
An expression vector comprising:
- (a) a first polynucleotide encoding a first, crippled, selectable marker;
- (b) a second polynucleotide encoding a heterologous polypeptide of interest;
- and
- (c) a third polynucleotide encoding a second, amplifiable selectable marker.
A plasmid selected from the group consisting of pESN1dhfr, pESN2dhfr, pESN3dhfr, pneoldhfr5′del, pneo3dhfr5′del, pneo2dhfr5′del, and pdhfr3′del.
A plasmid designated pESN1dhfr.
A plasmid designated pESN2dhfr.
A plasmid designated pESN3dhfr.
A plasmiddesignatedpneo1dhfr5′del.
A plasmid designated pneo3dhfr5′del.
A plasmid designated pneo2dhfr5′del.
A plasmid designated pdhfr3′del.
A transfection system comprising
- (a) a first construct comprising, in a suitable backbone, a sequence encoding a first selectable marker and a sequence encoding a second selectable marker, wherein the second selectable marker contains at least one disabling mutation in its coding sequence;
- and
- (b) a second construct comprising, in a suitable backbone, a polynucleotide sequence of interest and a sequence encoding a third selectable marker, wherein the third selectable marker is the same selectable marker as the second selectable marker except that the third selectable marker contains at least one disabling mutation that is in a different region of the coding sequence than the disabling mutation in said second selectable marker.
A method for producing a mammalian cell line for expression of a selected polynucleotide sequence, comprising
- (a) introducing into a selected mammalian cell, having a genome, a first construct comprising a sequence encoding a first selectable marker and a sequence encoding a second selectable marker, wherein the second selectable marker contains at least one disabling mutation in its coding sequence,
- (b) selecting for a mammalian cell expressing the first selectable marker, wherein said first construct stably integrates into the genome;
- (c) introducing into the mammalian cell a second construct comprising a polynucleotide sequence of interest and a sequence encoding a third selectable marker, wherein the third selectable marker is the same selectable marker as the second selectable marker except that the third selectable marker contains at least one disabling mutation that is in a different region of the coding sequence than the disabling mutation in said second selectable marker;
- and
- (d) selecting for a mammalian cell expressing a functional product encoded by the second selectable marker, wherein the functional product is encoded by a sequence produced by a recombination event between said second and third selectable markers, and the resulting mammalian cell is capable of expressing the selected polynucleotide sequence.
A method for producing a polypeptide of interest in a host mammalian cell, said method comprising:
- (a) introducing into said cell, having a genome, a first construct comprising a sequence encoding a first selectable marker and a sequence encoding a second selectable marker, wherein the second selectable marker contains at least one disabling mutation in its coding sequence;
- (b) selecting for a mammalian cell expressing the first selectable marker, wherein said first construct stably integrates into the genome;
- (c) introducing into the mammalian cell a second construct comprising a polynucleotide sequence encoding the polypeptide of interest and a sequence encoding a third selectable marker, wherein the third selectable marker is the same selectable marker as the second selectable marker except that the third selectable marker contains at least one disabling mutation that is in a different region of the coding sequence than the disabling mutation in said second selectable marker;
- (d) selecting for a mammalian cell expressing a functional product encoded by the second selectable marker, wherein the functional product is encoded by a sequence produced by a recombination event between said second and third selectable markers, and the resulting mammalian cell is capable of expressing the polypeptide of interest;
- and
- (e) culturing the mammalian cell under conditions to produce the polypeptide of interest.
Dependencies are inferred from the claim text.